GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 717 filers reported holding GLAXOSMITHKLINE PLC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $200,000 | +2.6% | 4,630 | 0.0% | 0.28% | +19.9% |
| Q1 2017 | $195,000 | +9.6% | 4,630 | 0.0% | 0.24% | +27.6% |
| Q4 2016 | $178,000 | -11.0% | 4,630 | 0.0% | 0.18% | -1.1% |
| Q3 2016 | $200,000 | -0.5% | 4,630 | 0.0% | 0.19% | 0.0% |
| Q2 2016 | $201,000 | -6.1% | 4,630 | 0.0% | 0.19% | -6.5% |
| Q1 2016 | $214,000 | +94.5% | 4,630 | +69.6% | 0.20% | +100.0% |
| Q4 2015 | $110,000 | +4.8% | 2,730 | 0.0% | 0.10% | +3.1% |
| Q3 2015 | $105,000 | -7.9% | 2,730 | 0.0% | 0.10% | +5.4% |
| Q2 2015 | $114,000 | -54.8% | 2,730 | -50.0% | 0.09% | -9.8% |
| Q1 2015 | $252,000 | +115.4% | 5,460 | +100.0% | 0.10% | +15.9% |
| Q4 2014 | $117,000 | -6.4% | 2,730 | 0.0% | 0.09% | -9.3% |
| Q3 2014 | $125,000 | -14.4% | 2,730 | 0.0% | 0.10% | -14.9% |
| Q2 2014 | $146,000 | 0.0% | 2,730 | 0.0% | 0.11% | +0.9% |
| Q1 2014 | $146,000 | – | 2,730 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |